Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01061
Species: Homo sapiens
Position : chr2:46550000-46555000
Year: 2019
Title: FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: lung adenocarcinoma
PMID:  31826955
MONDO: MONDO:0005032
Tissue: Lung
Tissue Ontology ID: UBERON:0002048
Cell Source: H2023
CVCL ID: CVCL_1512
Cell Type: lung adenocarcinoma cell
Cell Ontology ID: CL:0001069
Experiment Type: Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: CRISPR Knockout, ChIP-RT-qPCR, RT-RT-qPCR, Western blot
About Target Gene
Target gene : EPAS1
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01062 chr2:46523219-46568173 Breast breast carcinoma cell breast carcinoma
Expression of Target Genes for the Enhancer